Ecem Esencan

Ecem Esencan

Auto-generated profile, based on publicly available information

Ecem Esencan

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2018 in Aging Cell
Verified
Journal Article
Open access
PDF file
TWTian-ren Wang
Tian-ren Wang
EBElnur Babayev
Elnur Babayev
ZJZongliang Jiang
Zongliang Jiang
GLGuangxin Li
Guangxin Li
MZMan Zhang
Man Zhang
ESEmre Seli
Emre Seli
Summary: Caseinolytic peptidase P mediates degradation of unfolded mitochondrial proteins and activates mitochondrial unfolded protein response (mtUPR) to maintain protein homeostasis. Clpp−/− female mice generate a lower number of mature oocytes and two‐cell embryos, and no blastocysts. Clpp−/− oocytes have smaller mitochondria, with lower aspect ratio (length/width), and decreased expression of genes that promote fusion. A 4‐fold increase in atretic follicles at 3 months, and reduced number of primordial follicles at 6–12 months are observed in Clpp−/− ovaries. This is associated with upregulation of p‐S6, p‐S6K, p‐4EBP1 and p‐AKT473, p‐mTOR2481 consistent with mTORC1 and mTORC2 activation, respectively, and Clpp−/− oocyte competence is partially rescued by mTOR inhibitor rapamycin. Our findings demonstrate that CLPP is required for oocyte and embryo development and oocyte mitochondrial function and dynamics. Absence of CLPP results in mTOR pathway activation, and accelerated depletion of ovarian follicular reserve.

1 December 2018 in Fertility and Sterility
Verified
Journal Article
Closed access
TSTim Sanchez
Tim Sanchez
TWTian-ren Wang
Tian-ren Wang
MPMarta Venturas Pedro
Marta Venturas Pedro
MZMan Zhang
Man Zhang
EEEcem Esencan
Ecem Esencan
ESEmre Seli
Emre Seli

26 February 2019 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
EEEcem Esencan
Ecem Esencan
AKAmanda N. Kallen
Amanda N. Kallen
MZMan Zhang
Man Zhang
ESEmre Seli
Emre Seli
Transcription ceases upon stimulation of oocyte maturation and gene expression during oocyte maturation, fertilization, and early cleavage relies on translational activation of maternally derived mRNAs. Two key mechanisms that mediate translation of mRNAs in oocytes have been described in detail: cytoplasmic polyadenylation-dependent and -independent. Both of these mechanisms utilize specific protein complexes that interact with cis-acting sequences located on 3′-untranslated region (3′-UTR), and both involve embryonic poly(A) binding protein (EPAB), the predominant poly(A) binding protein during early development. While mechanistic details of these pathways have primarily been elucidated using the Xenopus model, their roles are conserved in mammals and targeted disruption of key regulators in mouse results in female infertility. Here, we provide a detailed account of the molecular mechanisms involved in translational activation during oocyte and early embryo development, and the role of EPAB in this process.

1 January 2017 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
OAOzge Nur Aktas
Ozge Nur Aktas
TGTugba Gursoy
Tugba Gursoy
ESElif Soysal
Elif Soysal
EEEcem Esencan
Ecem Esencan
SESecil Ercin
Secil Ercin
Background: Thyroid function tests in neonates have been challenging to interpret because their levels are affected by several neonatal and delivery-related factors. The aim of the study was to evaluate reference values of thyroxine (T4) and thyrotropin (TSH) levels in different gestational age groups and to demonstrate the affect of perinatal factors on thyroid hormones.Methods: Medical records of 7616 neonates whose gestational age ranges between 34 and 42 weeks were analyzed retrospectively. Gender, mode of delivery, gestational age, postnatal age and birth weight were noted together with TSH and T4 levels.Results: Gestational age (r=0.14, p<0.001) and birth weight (r=0.12, p<0.001) had positive correlation with T4 levels, whereas they had no effect on TSH levels. Males had higher TSH and lower T4 levels (p=0.001 for both) compared with females. T4 levels of babies born via vaginal delivery were lower than the ones born via cesarean section (p=0.01). Multivariable analysis yielded gestational age as the only factor affecting T4 levels (p<0.001). T4 and TSH levels based on 2.5–97.5 percentile cutoffs according to gestational age were presented.Conclusions: The thyroid hormone ranges given in this study can help pediatricians to interpret the thyroid hormone results with ease.

14 March 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
DIDeborah E Ikhena
Deborah E Ikhena
SLShimeng Liu
Shimeng Liu
SKStacy Kujawa
Stacy Kujawa
EEEcem Esencan
Ecem Esencan
JCJohn S Coon
John S Coon
PYPing Yin
Ping Yin
Context: Uterine leiomyomas are the most common type of gynecologic tumor in women. Objective: To determine the role of the cytokine receptor activator of nuclear factor κ-Β ligand (RANKL); its receptor, receptor activator of nuclear factor κ-Β (RANK); and the RANKL/RANK pathway inhibitor RANK-Fc in leiomyoma growth. Design: Messenger RNA (mRNA) or protein levels of RANKL, RANK, and proliferation markers cyclin D1 and Ki67 were assessed in various leiomyoma tissues and cell populations. Human xenograft experiments were performed to determine the effects of RANK-Fc on leiomyoma growth in vivo. Setting: Research laboratory. Patients: Twenty-four regularly cycling premenopausal women (age 28 to 49 years) who were not receiving hormone therapy. Interventions: None. Main Outcome Measure: Tumor growth in a murine xenograft model following targeting of the RANKL/RANK pathway with RANK-Fc. Results: RANKL mRNA levels in leiomyoma were significantly higher than those in myometrial tissues. The highest RANK levels were found in the leiomyoma stem cell population, which is deficient in progesterone receptor (PR). Conversely, the highest RANKL levels were found in the PR-rich leiomyoma intermediate cell (LIC) population. R5020, a PR agonist, specifically increased RANKL expression in LICs. RANK-Fc blocked RANKL-induced expression of the proliferative gene cyclin D1. Treatment with RANK-Fc also significantly decreased tumor growth in vivo and diminished the expression of proliferation marker Ki67 in tumors (P < 0.01; n = 4). Conclusions: Treatment with the RANKL/RANK pathway inhibitor RANK-Fc significantly decreased human leiomyoma cell proliferation and tumor growth. This suggests that the RANKL/RANK pathway could serve as a potential target for the prevention and treatment of uterine leiomyoma.

15 February 2017
Verified
Journal Article
Closed access
HZHong Zhao
Hong Zhao
YOYelda C Orhan
Yelda C Orhan
XZXiaoMing Zha
XiaoMing Zha
EEEcem Esencan
Ecem Esencan
RCRobert T Chatterton
Robert T Chatterton
SBSerdar E Bulun
Serdar E Bulun